Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Out of stock

Price data last checked 44 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 44 days. Could come back at any time — we're watching for you.

Out of stock 44 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
28 April 2024

Similar Products You Might Like

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 12 Jun 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India

£515.00 18 Jun 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 13 Jun 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States

£520.00 16 Jun 2026
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
98% match

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products

Price unavailable
The 2025-2030 World Outlook for Breast Cancer Screenings
98% match

The 2025-2030 World Outlook for Breast Cancer Screenings

Price unavailable
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy for US Zip Codes
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy for US Zip Codes

£490.00 12 Jun 2026
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
98% match

The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments

Price unavailable
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
98% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 11 Jul 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 18 Jun 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 13 Jun 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 17 Jun 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 11 Jul 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 15 Jul 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India

£515.00 17 Jun 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 15 Jul 2026
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
97% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 16 Jun 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 15 Jul 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
97% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 13 Jun 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 13 Jun 2026
The 2023-2028 Outlook for Breast Cancer Screenings for US Zip Codes
97% match

The 2023-2028 Outlook for Breast Cancer Screenings for US Zip Codes

£490.00 16 Jun 2026
The 2025-2030 World Outlook for Digital Breast Tomosynthesis
97% match

The 2025-2030 World Outlook for Digital Breast Tomosynthesis

Price unavailable
The 2025-2030 World Outlook for Ionizing Breast Imaging
97% match

The 2025-2030 World Outlook for Ionizing Breast Imaging

Price unavailable
The 2021-2026 World Outlook for Breast Biopsies
97% match

The 2021-2026 World Outlook for Breast Biopsies

Price unavailable